Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment

被引：16

作者：

Fusco, Vittorio ^{[1
]}

Loidoris, Anastasios ^{[1
]}

Colella, Giuseppe ^{[2
]}

Vescovi, Paolo ^{[3
]}

Campisi, Giuseppina ^{[4
]}

机构：

[1] Alessandria City Hosp, Oncol Unit, I-15100 Alessandria, Italy

[2] Univ Naples 2, I-80138 Naples, Italy

[3] Univ Parma, Oral Care Unit, I-43100 Parma, Italy

[4] Univ Palermo, Oral Med Unit, I-90127 Palermo, Italy

来源：

BREAST | 2010年 / 19卷 / 05期

关键词：

DENTAL PREVENTIVE MEASURES; BISPHOSPHONATES; IMPLEMENTATION;

D O I：

10.1016/j.breast.2010.03.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：432 / 433

页数：2

共 10 条

[1]

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].

Bamias, A ;

Kastritis, E ;

Bamia, C ;

Moulopoulos, LA ;

Melakopoulos, L ;

Bozas, G ;

Koutsoukou, V ;

Gika, D ;

Anagnostopoulos, A ;

Papadimitriou, C ;

Terpos, E ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587

[2]

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid [J].

Dimopoulos, M. A. ;

Kastritis, E. ;

Bamia, C. ;

Melakopoulos, I. ;

Gika, D. ;

Roussou, M. ;

Migkou, M. ;

Eleftherakis-Papaiakovou, E. ;

Christoulas, D. ;

Terpos, E. ;

Bamias, A. .

ANNALS OF ONCOLOGY, 2009, 20 (01) :117-120

[3]

Durie BGM, 2005, NEW ENGL J MED, V353, P99

[4]

Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatment [J].

Fehm, T. ;

Felsenberg, D. ;

Krimmel, M. ;

Solomayer, E. ;

Wallwiener, D. ;

Hadjii, P. .

BREAST, 2009, 18 (04) :213-217

[5]

JAW OSTEONECROSIS ASSOCIATED WITH INTRAVENOUS BISPHOSPHONATE: IS INCIDENCE REDUCED AFTER ADOPTION OF DENTAL PREVENTIVE MEASURES? [J].

Fusco, Vittorio ;

Baraldi, Anna ;

Loidoris, Anastasios ;

Ciuffreda, Libero ;

Galassi, Claudia ;

Goia, Franco ;

Scoletta, Matteo ;

Berrone, Sid ;

Benech, Arnaldo ;

Ortega, Cinzia ;

Berruti, Alfredo .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (08) :1775-1775

[6]

Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/JBMR.080205, 10.1359/jbmr.080205]

[7]

Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy [J].

Jung, Tatjana I. ;

Hoffmann, Falk ;

Glaeske, Gerd ;

Felsenberg, Dieter .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (03) :363-370

[8]

Bisphosphonates and Time to Osteonecrosis Development [J].

Palaska, Pinelopi Kleio ;

Cartsos, Vassiliki ;

Zavras, Athanasios I. .

ONCOLOGIST, 2009, 14 (11) :1154-1166

[9]

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan [J].

Ripamonti, C. I. ;

Maniezzo, M. ;

Campa, T. ;

Fagnoni, E. ;

Brunelli, C. ;

Saibene, G. ;

Bareggi, C. ;

Ascani, L. ;

Cislaghi, E. .

ANNALS OF ONCOLOGY, 2009, 20 (01) :137-145

[10]

Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw [J].

Vahtsevanos, Konstantinos ;

Kyrgidis, Athanassios ;

Verrou, Evgenia ;

Katodritou, Eirini ;

Triaridis, Stefanos ;

Andreadis, Charalampos G. ;

Boukovinas, Ioannis ;

Koloutsos, Georgios E. ;

Teleioudis, Zisis ;

Kitikidou, Kyriaki ;

Paraskevopoulos, Panagiotis ;

Zervas, Konstantinos ;

Antoniades, Konstantinos .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) :5356-5362

← 1 →